Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | OPRK1 | P41145 | 15/20 | 0.36 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.35 |
| ▸ | JAK2 | O60674 | 2/20 | 0.32 |
| ▸ | JAK1 | P23458 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29968653 | 1.00 | ALDH1A1 (0.36) | ALDH1A1MAPK1HTTOPRK1VCAM1 | |
| SCHEMBL29969671 | 0.85 | ALDH1A1 (0.40) | ALDH1A1MAPK1HTTOPRK1JAK2 | |
| SCHEMBL26127971 | 0.85 | ALDH1A1 (0.40) | ALDH1A1MAPK1HTTOPRK1JAK2 | |
| SCHEMBL22941968 | 0.83 | ALDH1A1 (0.43) | ALDH1A1MAPK1HTTOPRK1JAK2 | |
| SCHEMBL21513418 | 0.81 | OPRK1 (0.35) | OPRK1 | |
| SCHEMBL29969990 | 0.81 | OPRK1 (0.35) | OPRK1 | |
| SCHEMBL26590487 | 0.79 | OPRK1 (0.37) | OPRK1 | |
| SCHEMBL26130281 | 0.78 | ALDH1A1 (0.39) | ALDH1A1MAPK1HTTOPRK1JAK2 | |
| SCHEMBL29969938 | 0.78 | ALDH1A1 (0.40) | ALDH1A1MAPK1HTTOPRK1JAK2 | |
| SCHEMBL26131044 | 0.78 | ALDH1A1 (0.40) | ALDH1A1MAPK1HTTOPRK1JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4327877-A2 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | XRad Therapeutics, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-4327877-A2 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | XRad Therapeutics, Inc. (US) | 2024-02-28 | — | — | EP | disclosed |
| EP-3784671-B1 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | XRAD THERAPEUTICS INC (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-3784671-B1 | DUAL ATM AND DNA-PK INHIBITORS FOR USE IN ANTI-TUMOR THERAPY | XRAD THERAPEUTICS INC (US) | 2023-10-11 | — | — | EP | disclosed |